BBNX (Beta Bionics) Change In Inventory: $-7.5 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBNX Beta Bionics Inc BBNX
13 GF Score
Price $19.04
! 3 Warning Signs
View Full Analysis

What is Beta Bionics Change In Inventory?

Beta Bionics BBNX -2.26% 13 Change In Inventory is $-7.5 Mil as of Jun. 2026. GuruFocus rates BBNX with a GF Score™ of 13/100. The stock has 3 warning signs investors should review.

Beta Bionics's change in inventory for the quarter that ended in Jun. 2026 was $-0.2 Mil. It means Beta Bionics's inventory increased by $0.2 Mil from Mar. 2026 to Jun. 2026 .

Beta Bionics's change in inventory for the fiscal year that ended in Dec. 2025 was $-9.9 Mil. It means Beta Bionics's inventory increased by $9.9 Mil from Dec. 2024 to Dec. 2025 .

Beta Bionics's Total Inventories for the quarter that ended in Jun. 2026 was $23.9 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Beta Bionics's Days Inventory for the quarter that ended in Jun. 2026 was 165.80.

Inventory Turnover measures how fast the company turns over its inventory within a year. Beta Bionics's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.55.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Beta Bionics's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.74.

Beta Bionics  (NAS:BBNX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Beta Bionics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=23.8225/13.111*365 / 4
=165.80

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Beta Bionics's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=13.111 / 23.8225
=0.55

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Beta Bionics's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=23.8225 / 32.013
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics Change In Inventory Related Terms

Beta Bionics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Beta Bionics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics Change In Inventory Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Change In Inventory
0.00 -1.19 -11.44 -9.88

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.73 -3.33 -2.20 -1.80 -0.21
BBNX
13GF Score
Beta Bionics Inc BBNX
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-7.5 Mil mean?
Beta Bionics (BBNX) has a Change In Inventory of $-7.5 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Beta Bionics and its competitors.
Is Beta Bionics' Change In Inventory too high?
Beta Bionics' current Change In Inventory is $-7.5 Mil. Overall, Beta Bionics has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Change In Inventory compare to SSII and SIBN?
Beta Bionics' Change In Inventory of $-7.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Devices & Instruments company?
A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Beta Bionics and its competitors. Beta Bionics's current Change In Inventory is $-7.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Change In Inventory of $-7.5 Mil. The current Change In Inventory is $-7.5 Mil. Beta Bionics' overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Change In Inventory is $-7.5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
13GF Score

Get the complete analysis for BBNX

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.04
Price